AstraZeneca rejects Pfizer final bid of £69.3bn

Posted on 19 May 2014 by Victoria Fitzgerald
Pfizer confirms AstraZeneca takeover could lead to R&D and job cuts

US drug manufacturer Pfizer has made a final offer of £69.3bn for British firm AstraZeneca.

Pfizer released a statement saying this figure was final and would not be increased. The firm added it would not make a hostile bid directly to AstraZeneca shareholders and would only go ahead with the offer under the approval of AstraZeneca’s board. The cash element of the bid has been raised to 45%. Under the…

This content is for subscribers only. Subscribe now for free to read the full article.